Personalis Inc (NASDAQ: PSNL) has experienced a rise in its stock price by 8.16 compared to its previous closing price of 3.86. However, the company has seen a gain of 8.72% in its stock price over the last five trading days. businesswire.com reported 2025-04-28 that FREMONT, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced new interim analysis results of the VICTORI study showing strong performance of its ultra-sensitive NeXT Personal assay in detecting early signs of residual or recurrent colorectal cancer (CRC). The study, led by Dr. Jonathan Loree’s team at BC Cancer in Vancouver, Canada, utilized NeXT Personal to look for small traces of circulating tumor DNA (ctDNA) in bloo.
Is It Worth Investing in Personalis Inc (NASDAQ: PSNL) Right Now?
The 36-month beta value for PSNL is also noteworthy at 1.82. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for PSNL is 43.93M, and at present, short sellers hold a 10.04% of that float. The average trading volume of PSNL on May 02, 2025 was 914.15K shares.
PSNL’s Market Performance
The stock of Personalis Inc (PSNL) has seen a 8.72% increase in the past week, with a 17.28% rise in the past month, and a -20.02% fall in the past quarter. The volatility ratio for the week is 5.86%, and the volatility levels for the past 30 days are at 9.25% for PSNL. The simple moving average for the past 20 days is 20.47% for PSNL’s stock, with a -7.94% simple moving average for the past 200 days.
Analysts’ Opinion of PSNL
Many brokerage firms have already submitted their reports for PSNL stocks, with Craig Hallum repeating the rating for PSNL by listing it as a “Buy.” The predicted price for PSNL in the upcoming period, according to Craig Hallum is $8 based on the research report published on March 17, 2025 of the current year 2025.
Needham, on the other hand, stated in their research note that they expect to see PSNL reach a price target of $8. The rating they have provided for PSNL stocks is “Buy” according to the report published on February 06th, 2023.
PSNL Trading at 12.80% from the 50-Day Moving Average
After a stumble in the market that brought PSNL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.01% of loss for the given period.
Volatility was left at 9.25%, however, over the last 30 days, the volatility rate increased by 5.86%, as shares surge +26.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -23.02% lower at present.
During the last 5 trading sessions, PSNL rose by +8.85%, which changed the moving average for the period of 200-days by +107.96% in comparison to the 20-day moving average, which settled at $3.47. In addition, Personalis Inc saw -27.77% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PSNL starting from Tachibana Aaron, who sale 708 shares at the price of $5.79 back on Jan 28 ’25. After this action, Tachibana Aaron now owns 166,390 shares of Personalis Inc, valued at $4,099 using the latest closing price.
Chen Richard, the CHIEF MEDICAL OFFICER AND EVP of Personalis Inc, sale 519 shares at $5.79 during a trade that took place back on Jan 28 ’25, which means that Chen Richard is holding 123,367 shares at $3,005 based on the most recent closing price.
Stock Fundamentals for PSNL
Current profitability levels for the company are sitting at:
- -0.81 for the present operating margin
- 0.32 for the gross margin
The net margin for Personalis Inc stands at -0.96. The total capital return value is set at -0.29. Equity return is now at value -48.91, with -32.82 for asset returns.
Based on Personalis Inc (PSNL), the company’s capital structure generated 0.18 points at debt to capital in total, while cash flow to debt ratio is standing at -1.02. The debt to equity ratio resting at 0.22. The interest coverage ratio of the stock is -2625.65.
Currently, EBITDA for the company is -70.3 million with net debt to EBITDA at 0.67. When we switch over and look at the enterprise to sales, we see a ratio of 3.76. The receivables turnover for the company is 10.39for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.46.
Conclusion
In summary, Personalis Inc (PSNL) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
